MiR‐590 Promotes Transdifferentiation of Porcine and Human Fibroblasts Toward a Cardiomyocyte‐Like Fate by Directly Repressing Specificity Protein 1
Open Access
- 26 October 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 5 (11)
Abstract
Background: Reprogramming of cardiac fibroblasts into induced cardiomyocyte‐like cells represents a promising potential new therapy for treating heart disease, inducing significant improvements in postinfarct ventricular function in rodent models. Because reprogramming factors effective in transdifferentiating rodent cells are not sufficient to reprogram human cells, we sought to identify reprogramming factors potentially applicable to human studies. Methods and Results: Lentivirus vectors expressing Gata4, Mef2c, and Tbx5 ( GMT ); Hand2 (H), Myocardin (My), or microRNA (miR)‐590 were administered to rat, porcine, and human cardiac fibroblasts in vitro. induced cardiomyocyte‐like cell production was then evaluated by assessing expression of the cardiomyocyte marker, cardiac troponin T ( cTnT ), whereas signaling pathway studies were performed to identify reprogramming factor targets. GMT administration induced cTnT expression in ≈6% of rat fibroblasts, but failed to induce cTnT expression in porcine or human cardiac fibroblasts. Addition of H/My and/or miR‐590 to GMT administration resulted in cTNT expression in ≈5% of porcine and human fibroblasts and also upregulated the expression of the cardiac genes, MYH 6 and TNNT 2. When cocultured with murine cardiomyocytes, cTnT ‐expressing porcine cardiac fibroblasts exhibited spontaneous contractions. Administration of GMT plus either H/My or miR‐590 alone also downregulated fibroblast genes COL 1A1 and COL 3A1. miR‐590 was shown to directly suppress the zinc finger protein, specificity protein 1 (Sp1), which was able to substitute for miR‐590 in inducing cellular reprogramming. Conclusions: These data support porcine studies as a surrogate for testing human cardiac reprogramming, and suggest that miR‐590‐mediated repression of Sp1 represents an alternative pathway for enhancing human cardiac cellular reprogramming.Keywords
This publication has 44 references indexed in Scilit:
- Common miR-590 Variant rs6971711 Present Only in African Americans Reduces miR-590 BiogenesisPLOS ONE, 2016
- MicroRNA-590 is an EMT-suppressive microRNA involved in the TGFβ signaling pathwayMolecular Medicine Reports, 2015
- Sp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II-Induced Cardiac Fibrosis via Mechanism Involving the TGF-β and MAPKs Pathways in Cardiac FibroblastsPLOS ONE, 2015
- Inhibitory Effect of Hsa‐miR‐590‐5p on Cardiosphere‐derived Stem Cells Differentiation Through Downregulation of TGFB SignalingJournal of Cellular Biochemistry, 2014
- MiR‐133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signaturesThe EMBO Journal, 2014
- Direct Reprogramming of Human Fibroblasts to Functional and Expandable HepatocytesCell Stem Cell, 2014
- Induction of human cardiomyocyte-like cells from fibroblasts by defined factorsProceedings of the National Academy of Sciences, 2013
- Evaluating the MicroRNA Targeting Sites by Luciferase Reporter Gene Assay2012
- Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-κB activationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Interaction of Myocytes and Nonmyocytes Is Necessary for Mechanical Stretch to Induce ANP/BNP Production in Cardiocyte CultureJournal of Cardiovascular Pharmacology, 1998